SARS-COV2 INFECTION
Clinical trials for SARS-COV2 INFECTION explained in plain language.
Never miss a new study
Get alerted when new SARS-COV2 INFECTION trials appear
Sign up with your email to follow new studies for SARS-COV2 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New COVID booster shows promise in trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new booster vaccine (PHH-1V81) in 913 adults who had already received an mRNA COVID-19 vaccine. The goal was to see if the new booster is safe and improves immunity against newer virus variants. Participants received either the new booster or an existing one, …
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:06 UTC
-
Paris shelter study reveals hidden COVID-19 spread among homeless
Knowledge-focused CompletedThis study looked at how many people in homeless shelters in Paris had COVID-19 antibodies after the first wave. Researchers tested 179 residents and staff from three shelters to measure past infections and deaths. The goal was to understand the virus's impact on a vulnerable pop…
Matched conditions: SARS-COV2 INFECTION
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:06 UTC
-
Massive study aims to unravel mysteries of long COVID
Knowledge-focused CompletedThis study followed over 15,000 adults with and without COVID-19 to learn why some people develop long-term symptoms (Long COVID). Researchers tracked health, symptoms, and medical records over time. The goal was to identify risk factors and patterns of Long COVID, not to test a …
Matched conditions: SARS-COV2 INFECTION
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:02 UTC
-
Could an old antidepressant tweak immune cells in COVID-19?
Knowledge-focused CompletedThis study looked at how phenelzine, a monoamine oxidase inhibitor, affects immune cells in 51 adults with COVID-19. Researchers measured changes in T cells and monocytes to understand immune activation. The goal was to gather knowledge, not to treat or cure the disease.
Matched conditions: SARS-COV2 INFECTION
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC